Washington, United States,
08048034981

OBESITY/WEIGHT MANAGEMENT · Semaglutide

Semasize 0.25mg/0.5mg Pen Injection

In stock

Description

Semasize is a brand of semaglutide injection manufactured by Alkem Laboratories, designed for the treatment of type 2 diabetes and chronic weight management. While the specific “2.25mg/ml” concentration is not explicitly listed, Semasize is available in several other strengths (0.25mg/0.5mg, 1mg, 2mg, 2.4mg, and 8mg).

Specifications

Strength 0.25mg/0.5 ml
Pack Contains 1 Multi-dose Disposable Pen, Needles, Alcohol Swabs
Therapeutic Category GLP-1 receptor agonist (Incretin mimetics).
Active Ingrtedients Semaglutide